You are here: Industry Insights > COVID-19

News List

AYUSH Ministry initiates efforts to bring Indian traditional medicines under D&C Act 1940 expresspharma
April 29, 2020
A notification informs that scientists, researchers, clinicians can carry out research on COVID-19 through Ayurveda, Homeopathy systems, provided they adhere to certain mandatory steps.
India’s pharma capabilities would remain available to the world: PM Modi expresspharma
April 29, 2020
This message was part of his telephone conversation with Justin Trudeau, Prime Minister of Canada.
Strides develops and commences export of Favipiravir Antiviral Tablets expresspharma
April 29, 2020
The product is currently being exported to GCC countries to treat patients under their treatment program for COVID-19.
IIT Guwahati collaborates with Hester Biosciences to develop vaccine against COVID-19 expresspharma
April 29, 2020
The vaccine will be based on recombinant avian paramyxovirus-based vector platform, the company said.
Serum Institute plans to price coronavirus vaccine at ₹1,000 if trials succeed expresspharma
April 29, 2020
The Serum Institute of India announced that it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
Regeneron, Sanofi Release Preliminary Phase II Kevzara Results in COVID-19 contractpharma
April 28, 2020
Kevzara rapidly lowered C-reactive protein (CRP), a key marker of inflammation, meeting the primary endpoint.
AGC Biologics, AdaptVac Partner to Develop COVID-19 Vaccine contractpharma
April 28, 2020
Will leverage AdaptVac's Virus-Like Particle (VLP) technology that could provide a solution to protect against new SARS-CoV-2 infections.
Santhera, CSHL to Investigate Lonodelestat in COVID-19-related ARDS contractpharma
April 28, 2020
Lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase (hNE), has potential as a therapeutic intervention for COVID-19-related ARDS.
CRO Industry Update contractpharma
April 28, 2020
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
Valo Tx Working to Develop Potential COVID-19 Vaccine contractpharma
April 28, 2020
Will use PeptiCRAd technology with HLA-matched peptides optimized to further boost CD8+ T-cell immune responses.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page